The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation
The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this dom...
Saved in:
| Published in | Oncogene Vol. 27; no. 14; pp. 2064 - 2071 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
27.03.2008
Nature Publishing Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0950-9232 1476-5594 1476-5594 |
| DOI | 10.1038/sj.onc.1210841 |
Cover
| Abstract | The
BCR-ABL
oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype. |
|---|---|
| AbstractList | The
BCR-ABL
oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype. The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype. [PUBLICATION ABSTRACT] The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype. The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype.The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype. The BCR-ABL oncogene encodes an in-frame fusion protein containing NH 2 -terminal sequences derived from Bcr and COOH-terminal sequences derived from Abl. Bcr contains a centrally located RhoGEF domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype. The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr contains a centrally located Rho-specific guanine nucleotide exchange factor (RhoGEF) domain that is retained within p210 Bcr-Abl. Although this domain is subject to autoinhibition in the context of Bcr, here we show that it is constitutively activated in p210 Bcr-Abl. p210 Bcr-Abl can stimulate RhoA activation independently of its tyrosine kinase activity, and mutations within the RhoGEF domain that are predicted to eliminate RhoGEF activity inhibit RhoA activation. The RhoGEF mutant of p210 Bcr-Abl does not affect the tyrosine kinase activity of the molecule, nor the ability of p210 Bcr-Abl to interact with XPB through the RhoGEF domain. Despite retaining normal levels of tyrosine kinase activity, the RhoGEF mutant of p210 Bcr-Abl is impaired in transforming activity as measured by anchorage-independent growth. However, the mutant is still able to confer the phenotype of growth factor independence in myeloid cells, suggesting that some, but not all parameters of p210 Bcr-Abl transformation, are dependent upon a catalytically active RhoGEF domain. Collectively, these observations identify a gain-of-function activity attributable to the RhoGEF domain of p210 Bcr-Abl that is required to support the transformed phenotype.Oncogene (2008) 27, 2064-2071; doi:10.1038/sj.onc.1210841; published online 8 October 2007 |
| Audience | Academic |
| Author | Pannucci, N L Megjugorac, N J Sahay, S Kostenko, E V Mahon, G M Whitehead, I P Rodriguez, P L Ozer, H L |
| Author_xml | – sequence: 1 givenname: S surname: Sahay fullname: Sahay, S organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 2 givenname: N L surname: Pannucci fullname: Pannucci, N L organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 3 givenname: G M surname: Mahon fullname: Mahon, G M organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 4 givenname: P L surname: Rodriguez fullname: Rodriguez, P L organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 5 givenname: N J surname: Megjugorac fullname: Megjugorac, N J organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 6 givenname: E V surname: Kostenko fullname: Kostenko, E V organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 7 givenname: H L surname: Ozer fullname: Ozer, H L organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey – sequence: 8 givenname: I P surname: Whitehead fullname: Whitehead, I P email: whiteip@umdnj.edu organization: Department of Microbiology and Molecular Genetics, New Jersey Medical School-University Hospital Cancer Center, University of Medicine and Dentistry of New Jersey |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20272724$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17922031$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFksFr2zAUxsXoWNNu1x2H2GhvTvVk2bIuhay03aAw2LqzkGU5UbClVLIL---ntF6zloWhg4X8-7739PQdoQPnnUHoPZA5kLw6i-u5d3oOFEjF4BWaAeNlVhSCHaAZEQXJBM3pITqKcU0I4YLQN-gQuKCU5DBDP25XBn9f-evLK9z4XlmHfYs3yQ5_1iFb1B1WerD3ajBxyy2wcg22EQdzN9pgGtz6gIegXEybXg3Wu7fodau6aN5N32P08-ry9uJLdvPt-uvF4ibTJedDJpraFBxYWYmm4W3DS-CKUE4LAaxOvRfQ8JqLVtdQiZqVoqhIyUgJwCqgIj9G54--m7HuTaONS310chNsr8Iv6ZWVz_84u5JLfy9pycuSs2RwOhkEfzeaOMjeRm26Tjnjxyg5YYwBEf8FKeSE5lAl8NMLcO3H4NIUUlEGOYeCkER93EtRnhdAHm43WS1VZ6R1rU930Nu6cgGCcCbSQBI1_weVVmN6q1NWWpvOnwk-_D20p2n9iUQCTiZARa26Nj2ttvGJo9sX4pTtKuvgYwym3VkRuc2mjGuZsimnbCYBeyHQdngITGrZdvtlZ4-ymPzd0oTdsPYofgN_4PKp |
| CODEN | ONCNES |
| CitedBy_id | crossref_primary_10_1111_j_1349_7006_2012_02346_x crossref_primary_10_1186_s12943_016_0516_4 crossref_primary_10_18632_oncoscience_260 crossref_primary_10_3389_fphar_2021_669469 crossref_primary_10_1016_j_biopha_2015_06_004 crossref_primary_10_1038_leu_2012_351 crossref_primary_10_1002_cncr_24485 crossref_primary_10_1016_j_jaccao_2022_06_004 crossref_primary_10_1182_blood_2011_06_359232 crossref_primary_10_1002_pmic_200900602 crossref_primary_10_1002_jcp_24819 crossref_primary_10_1016_j_pneurobio_2011_04_011 crossref_primary_10_3109_10428194_2010_546921 crossref_primary_10_1016_j_leukres_2020_106440 crossref_primary_10_1038_s41467_017_02313_6 crossref_primary_10_1158_0008_5472_CAN_18_1889 crossref_primary_10_1038_nrc2960 crossref_primary_10_1182_blood_2011_06_361709 crossref_primary_10_1074_mcp_M112_025908 crossref_primary_10_3324_haematol_2022_280757 crossref_primary_10_1038_bcj_2013_36 crossref_primary_10_1152_physrev_00045_2020 crossref_primary_10_1038_leu_2017_61 crossref_primary_10_1186_1756_9966_29_111 crossref_primary_10_1186_1476_4598_11_16 crossref_primary_10_1371_journal_pone_0076527 crossref_primary_10_1182_blood_2013_01_481184 crossref_primary_10_1016_j_mcn_2017_01_007 |
| Cites_doi | 10.1002/j.1460-2075.1993.tb05797.x 10.1158/0008-5472.CAN-06-0536 10.1073/pnas.85.23.9312 10.1128/MCB.11.4.1785 10.1073/pnas.92.22.10282 10.1182/blood.V99.11.4122 10.1128/MCB.11.3.1553 10.1172/JCI119520 10.1073/pnas.95.20.11858 10.1016/S0960-9822(03)00090-3 10.1074/jbc.M112397200 10.1016/0092-8674(91)90148-R 10.1128/MCB.9.3.1263 10.1073/pnas.96.1.203 10.1038/315550a0 10.1128/MCB.17.3.1346 10.1158/0008-5472.CAN-03-3656 10.1016/S0959-437X(95)90049-7 10.1038/sj.onc.1205678 10.1016/S0092-8674(05)80094-7 10.1038/sj.onc.1206626 10.1128/MCB.15.3.1286 10.1126/science.2408149 |
| ContentType | Journal Article |
| Copyright | Springer Nature Limited 2008 2008 INIST-CNRS COPYRIGHT 2008 Nature Publishing Group Copyright Nature Publishing Group Mar 27, 2008 Nature Publishing Group 2008. |
| Copyright_xml | – notice: Springer Nature Limited 2008 – notice: 2008 INIST-CNRS – notice: COPYRIGHT 2008 Nature Publishing Group – notice: Copyright Nature Publishing Group Mar 27, 2008 – notice: Nature Publishing Group 2008. |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TM 7TO 7U9 7X7 7XB 88A 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. LK8 M0S M1P M2O M7P MBDVC P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM |
| DOI | 10.1038/sj.onc.1210841 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Research Library Biological Science Database Research Library (Corporate) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Research Library Prep MEDLINE MEDLINE - Academic Research Library Prep AIDS and Cancer Research Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology |
| EISSN | 1476-5594 |
| EndPage | 2071 |
| ExternalDocumentID | PMC2676674 1454932761 A190749695 17922031 20272724 10_1038_sj_onc_1210841 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA097066 – fundername: NIA NIH HHS grantid: AG04821 – fundername: NIA NIH HHS grantid: R01 AG004821 – fundername: NCI NIH HHS grantid: R01 CA097066 |
| GroupedDBID | --- -Q- 0R~ 123 29N 2WC 36B 39C 3O- 3V. 4.4 406 53G 5RE 70F 7X7 88A 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AANZL AAYZH AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACUHS ACZOJ ADBBV ADFRT ADHDB AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFKRA AFSHS AGHAI AGQEE AHMBA AHSBF AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FEDTE FERAY FIZPM FRP FSGXE FYUFA GNUQQ GUQSH HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ITC IWAJR JSO JZLTJ KQ8 L7B LK8 M0L M1P M2O M7P N9A NAO NQJWS NXXTH O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TSG TUS UKHRP W2D WH7 ~8M AASML AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEFQL AEZWR AFDZB AFHIU AHWEU AIGIU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT .55 .GJ AACDK AATNV ABEFU ABRTQ AFFNX BAWUL FIGPU IQODW LGEZI LOTEE NADUK PJZUB PPXIY PQGLB TR2 UDS X7M ZXP CGR CUY CVF ECM EIF NPM AEIIB PMFND 7TM 7TO 7U9 7XB 8FD 8FK FR3 H94 K9. MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 PUEGO 7X8 5PM |
| ID | FETCH-LOGICAL-c677t-9dbe5714689dd7fd7617a02725914b09551d7b79fcb189b469580640611481293 |
| IEDL.DBID | 7X7 |
| ISSN | 0950-9232 1476-5594 |
| IngestDate | Thu Aug 21 18:11:40 EDT 2025 Fri Sep 05 12:36:55 EDT 2025 Thu Sep 04 15:31:07 EDT 2025 Sat Aug 16 22:22:03 EDT 2025 Fri Jul 25 09:09:28 EDT 2025 Tue Jun 17 22:22:20 EDT 2025 Tue Jun 10 21:13:10 EDT 2025 Mon Jul 21 05:44:33 EDT 2025 Mon Jul 21 09:12:06 EDT 2025 Tue Jul 01 02:23:37 EDT 2025 Thu Apr 24 23:01:21 EDT 2025 Fri Feb 21 02:39:35 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 14 |
| Keywords | chronic myelogenous leukemia p210 Bcr-Abl transformation RhoA RhoGEF domain Enzyme Triphosphoric monoester hydrolases Chronic myelogenous leukemia dGTPase Esterases Malignant hemopathy Carcinogenesis Myeloproliferative syndrome Hydrolases Cancer |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c677t-9dbe5714689dd7fd7617a02725914b09551d7b79fcb189b469580640611481293 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.nature.com/articles/1210841.pdf |
| PMID | 17922031 |
| PQID | 227351029 |
| PQPubID | 36330 |
| PageCount | 8 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2676674 proquest_miscellaneous_70444109 proquest_miscellaneous_21302318 proquest_journals_2641371500 proquest_journals_227351029 gale_infotracmisc_A190749695 gale_infotracacademiconefile_A190749695 pubmed_primary_17922031 pascalfrancis_primary_20272724 crossref_primary_10_1038_sj_onc_1210841 crossref_citationtrail_10_1038_sj_onc_1210841 springer_journals_10_1038_sj_onc_1210841 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-03-27 |
| PublicationDateYYYYMMDD | 2008-03-27 |
| PublicationDate_xml | – month: 03 year: 2008 text: 2008-03-27 day: 27 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: Basingstoke – name: England – name: New York |
| PublicationTitle | Oncogene |
| PublicationTitleAbbrev | Oncogene |
| PublicationTitleAlternate | Oncogene |
| PublicationYear | 2008 |
| Publisher | Nature Publishing Group UK Nature Publishing Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing – name: Nature Publishing Group |
| References | Lugo, Pendergast, Muller, Witte (CR7) 1990; 247 Pendergast, Muller, Havlik, Maru, Witte (CR14) 1991; 66 Skorski, Wlodarski, Daheron, Salomoni, Nieborowska-Skorska, Majewski (CR21) 1998; 95 Wertheim, Forsythe, Druker, Hammer, Boettiger, Pear (CR24) 2002; 99 Takeda, Shibuya, Maru (CR22) 1999; 96 Muller, Young, Pendergast, Pondel, Landau, Littman (CR12) 1991; 11 Salgia, Li, Ewaniuk, Pear, Pisick, Burky (CR19) 1997; 100 Shtivelman, Lifshitz, Gale, Canaani (CR20) 1985; 315 Renshaw, McWhirter, Wang (CR17) 1995; 15 Daley, Baltimore (CR3) 1998; 85 Lugo, Witte (CR8) 1989; 9 Harnois, Constantin, Rioux, Grenioux, Kitzis, Bourmeyster (CR5) 2003; 22 Ramaraj, Singh, Niu, Chu, Holtz, Yee (CR16) 2004; 64 Chuang, Xu, Kaartinen, Heisterkamp, Groffen, Bokoch (CR2) 1995; 92 McWhirter, Wang (CR11) 1993; 12 McWhirter, Wang (CR10) 1991; 11 Olabisi, Mahon, Kostenko, Liu, Ozer, Whitehead (CR13) 2006; 66 Bassermann, Jahn, Miething, Seipel, Bai, Coutinho (CR1) 2002; 277 Mahon, Wang, Korus, Kostenko, Cheng, Sun (CR9) 2003; 13 Whitehead, Campbell, Rossman, Der (CR25) 1997; 1332 ten Hoeve, Kaartinen, Fioretos, Haataja, Voncken, Heisterkamp (CR23) 1994; 54 Pendergast, Quilliam, Cripe, Bassing, Dai, Li (CR15) 1993; 75 Korus, Mahon, Cheng, Whitehead (CR6) 2002; 21 Ridley (CR18) 1995; 5 Han, Das, Wei, Van Aelst, Mosteller, Khosravi-Far (CR4) 1997; 17 R Salgia (BF1210841_CR19) 1997; 100 M Korus (BF1210841_CR6) 2002; 21 AJ Ridley (BF1210841_CR18) 1995; 5 TH Chuang (BF1210841_CR2) 1995; 92 AM Pendergast (BF1210841_CR14) 1991; 66 GM Mahon (BF1210841_CR9) 2003; 13 OO Olabisi (BF1210841_CR13) 2006; 66 GQ Daley (BF1210841_CR3) 1998; 85 J Han (BF1210841_CR4) 1997; 17 JR McWhirter (BF1210841_CR11) 1993; 12 JR McWhirter (BF1210841_CR10) 1991; 11 MW Renshaw (BF1210841_CR17) 1995; 15 TG Lugo (BF1210841_CR7) 1990; 247 T Harnois (BF1210841_CR5) 2003; 22 AJ Muller (BF1210841_CR12) 1991; 11 F Bassermann (BF1210841_CR1) 2002; 277 N Takeda (BF1210841_CR22) 1999; 96 J ten Hoeve (BF1210841_CR23) 1994; 54 IP Whitehead (BF1210841_CR25) 1997; 1332 P Ramaraj (BF1210841_CR16) 2004; 64 AM Pendergast (BF1210841_CR15) 1993; 75 E Shtivelman (BF1210841_CR20) 1985; 315 JA Wertheim (BF1210841_CR24) 2002; 99 T Skorski (BF1210841_CR21) 1998; 95 TG Lugo (BF1210841_CR8) 1989; 9 |
| References_xml | – volume: 12 start-page: 1533 year: 1993 end-page: 1546 ident: CR11 article-title: An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias publication-title: EMBO J doi: 10.1002/j.1460-2075.1993.tb05797.x – volume: 66 start-page: 6250 year: 2006 end-page: 6257 ident: CR13 article-title: Bcr interacts with components of the endosomal sorting complex required for transport-I and is required for epidermal growth factor receptor turnover publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0536 – volume: 1332 start-page: F1 year: 1997 end-page: F23 ident: CR25 article-title: Dbl family proteins publication-title: Biochim Biophys Acta – volume: 85 start-page: 9312 year: 1998 end-page: 9316 ident: CR3 article-title: Transformation of an interleukin 3-dependent hematopoietic cell-line by the chronic myelogenous leukemia-specific p210 Bcr-Abl protein publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.85.23.9312 – volume: 11 start-page: 1785 year: 1991 end-page: 1792 ident: CR12 article-title: BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias publication-title: Mol Cell Biol doi: 10.1128/MCB.11.4.1785 – volume: 92 start-page: 10282 year: 1995 end-page: 10286 ident: CR2 article-title: Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.92.22.10282 – volume: 99 start-page: 4122 year: 2002 end-page: 4130 ident: CR24 article-title: BCR-ABL-induced adhesion defects are tyrosine kinase-independent publication-title: Blood doi: 10.1182/blood.V99.11.4122 – volume: 11 start-page: 1553 year: 1991 end-page: 1565 ident: CR10 article-title: Activation of tyrosine kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins publication-title: Mol Cell Biol doi: 10.1128/MCB.11.3.1553 – volume: 100 start-page: 46 year: 1997 end-page: 57 ident: CR19 article-title: induces multiple abnormalities of cytoskeletal function publication-title: J Clin Invest doi: 10.1172/JCI119520 – volume: 95 start-page: 11858 year: 1998 end-page: 11862 ident: CR21 article-title: BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.20.11858 – volume: 13 start-page: 437 year: 2003 end-page: 441 ident: CR9 article-title: The c-Myc oncoprotein interacts with Bcr publication-title: Curr Biol doi: 10.1016/S0960-9822(03)00090-3 – volume: 277 start-page: 12437 year: 2002 end-page: 12445 ident: CR1 article-title: Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway publication-title: J Biol Chem doi: 10.1074/jbc.M112397200 – volume: 66 start-page: 161 year: 1991 end-page: 171 ident: CR14 article-title: BCR sequences essential for transformation by the oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner publication-title: Cell doi: 10.1016/0092-8674(91)90148-R – volume: 9 start-page: 1263 year: 1989 end-page: 1270 ident: CR8 article-title: The Bcr-Abl oncogene transforms Rat-1 cells and cooperates with v-myc publication-title: Mol Cell Biol doi: 10.1128/MCB.9.3.1263 – volume: 96 start-page: 203 year: 1999 end-page: 207 ident: CR22 article-title: The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.1.203 – volume: 315 start-page: 550 year: 1985 end-page: 554 ident: CR20 article-title: Fused transcript of abl and bcr genes in chronic melogenous leukaemia publication-title: Nature doi: 10.1038/315550a0 – volume: 17 start-page: 1346 year: 1997 end-page: 1353 ident: CR4 article-title: Lck regulates Vav activation of members of the Rho family of GTPases publication-title: Mol Cell Biol doi: 10.1128/MCB.17.3.1346 – volume: 64 start-page: 5322 year: 2004 end-page: 5331 ident: CR16 article-title: Effect of mutational inactivation of tyrosine kinase activity on BCR/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-3656 – volume: 5 start-page: 24 year: 1995 end-page: 30 ident: CR18 article-title: Rho-related proteins: actin cytoskeleton and cell cycle publication-title: Curr Opin Genet Dev doi: 10.1016/S0959-437X(95)90049-7 – volume: 21 start-page: 4601 year: 2002 end-page: 4612 ident: CR6 article-title: p38 MAPK-mediated activation of NF-κB by the RhoGEF domain of Bcr publication-title: Oncogene doi: 10.1038/sj.onc.1205678 – volume: 75 start-page: 175 year: 1993 end-page: 185 ident: CR15 article-title: BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein publication-title: Cell doi: 10.1016/S0092-8674(05)80094-7 – volume: 22 start-page: 6445 year: 2003 end-page: 6454 ident: CR5 article-title: Differential interaction and activation of Rho family GTPases by p210 and p190 publication-title: Oncogene doi: 10.1038/sj.onc.1206626 – volume: 54 start-page: 2563 year: 1994 end-page: 2567 ident: CR23 article-title: Cellular interactions of CRKL, an SH2–SH3 adaptor protein publication-title: Cancer Res – volume: 15 start-page: 1286 year: 1995 end-page: 1293 ident: CR17 article-title: The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation publication-title: Mol Cell Biol doi: 10.1128/MCB.15.3.1286 – volume: 247 start-page: 1079 year: 1990 end-page: 1082 ident: CR7 article-title: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products publication-title: Science doi: 10.1126/science.2408149 – volume: 21 start-page: 4601 year: 2002 ident: BF1210841_CR6 publication-title: Oncogene doi: 10.1038/sj.onc.1205678 – volume: 5 start-page: 24 year: 1995 ident: BF1210841_CR18 publication-title: Curr Opin Genet Dev doi: 10.1016/S0959-437X(95)90049-7 – volume: 247 start-page: 1079 year: 1990 ident: BF1210841_CR7 publication-title: Science doi: 10.1126/science.2408149 – volume: 92 start-page: 10282 year: 1995 ident: BF1210841_CR2 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.92.22.10282 – volume: 22 start-page: 6445 year: 2003 ident: BF1210841_CR5 publication-title: Oncogene doi: 10.1038/sj.onc.1206626 – volume: 99 start-page: 4122 year: 2002 ident: BF1210841_CR24 publication-title: Blood doi: 10.1182/blood.V99.11.4122 – volume: 85 start-page: 9312 year: 1998 ident: BF1210841_CR3 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.85.23.9312 – volume: 15 start-page: 1286 year: 1995 ident: BF1210841_CR17 publication-title: Mol Cell Biol doi: 10.1128/MCB.15.3.1286 – volume: 54 start-page: 2563 year: 1994 ident: BF1210841_CR23 publication-title: Cancer Res – volume: 17 start-page: 1346 year: 1997 ident: BF1210841_CR4 publication-title: Mol Cell Biol doi: 10.1128/MCB.17.3.1346 – volume: 95 start-page: 11858 year: 1998 ident: BF1210841_CR21 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.95.20.11858 – volume: 12 start-page: 1533 year: 1993 ident: BF1210841_CR11 publication-title: EMBO J doi: 10.1002/j.1460-2075.1993.tb05797.x – volume: 75 start-page: 175 year: 1993 ident: BF1210841_CR15 publication-title: Cell doi: 10.1016/S0092-8674(05)80094-7 – volume: 1332 start-page: F1 year: 1997 ident: BF1210841_CR25 publication-title: Biochim Biophys Acta – volume: 66 start-page: 161 year: 1991 ident: BF1210841_CR14 publication-title: Cell doi: 10.1016/0092-8674(91)90148-R – volume: 277 start-page: 12437 year: 2002 ident: BF1210841_CR1 publication-title: J Biol Chem doi: 10.1074/jbc.M112397200 – volume: 11 start-page: 1553 year: 1991 ident: BF1210841_CR10 publication-title: Mol Cell Biol doi: 10.1128/MCB.11.3.1553 – volume: 100 start-page: 46 year: 1997 ident: BF1210841_CR19 publication-title: J Clin Invest doi: 10.1172/JCI119520 – volume: 9 start-page: 1263 year: 1989 ident: BF1210841_CR8 publication-title: Mol Cell Biol doi: 10.1128/MCB.9.3.1263 – volume: 66 start-page: 6250 year: 2006 ident: BF1210841_CR13 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-06-0536 – volume: 96 start-page: 203 year: 1999 ident: BF1210841_CR22 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.96.1.203 – volume: 13 start-page: 437 year: 2003 ident: BF1210841_CR9 publication-title: Curr Biol doi: 10.1016/S0960-9822(03)00090-3 – volume: 315 start-page: 550 year: 1985 ident: BF1210841_CR20 publication-title: Nature doi: 10.1038/315550a0 – volume: 64 start-page: 5322 year: 2004 ident: BF1210841_CR16 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-03-3656 – volume: 11 start-page: 1785 year: 1991 ident: BF1210841_CR12 publication-title: Mol Cell Biol doi: 10.1128/MCB.11.4.1785 |
| SSID | ssj0007902 |
| Score | 2.0606713 |
| Snippet | The
BCR-ABL
oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr... The BCR-ABL oncogene encodes an in-frame fusion protein containing N-terminal sequences derived from Bcr and C-terminal sequences derived from Abl. Bcr... The BCR-ABL oncogene encodes an in-frame fusion protein containing NH 2 -terminal sequences derived from Bcr and COOH-terminal sequences derived from Abl. Bcr... |
| SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2064 |
| SubjectTerms | Animals Apoptosis BCR-ABL protein Biological and medical sciences cdc42 GTP-Binding Protein - metabolism Cell Biology Cell Line Cell physiology Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - metabolism Cellular proteins Enzyme Activation Fundamental and applied biological sciences. Psychology Fusion protein Fusion Proteins, bcr-abl - chemistry Fusion Proteins, bcr-abl - genetics Fusion Proteins, bcr-abl - metabolism Genetic transformation Genetics Guanine Guanine nucleotide exchange factor Guanine Nucleotide Exchange Factors - chemistry Hematologic and hematopoietic diseases Human Genetics Humans Internal Medicine Kinases Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Medical sciences Medicine Medicine & Public Health Mice Molecular and cellular biology Molecular biology Mutants Mutation Myeloid cells Myeloid Cells - metabolism Oncogenes Oncology original-article Phenotypes Physiological aspects Point Mutation Protein kinases Protein Structure, Tertiary - genetics Protein-tyrosine kinase Proteins Proto-Oncogene Proteins c-bcr - chemistry Proto-Oncogene Proteins c-bcr - genetics Proto-Oncogene Proteins c-bcr - metabolism Rho Guanine Nucleotide Exchange Factors rhoA GTP-Binding Protein - metabolism RhoA protein |
| Title | The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation |
| URI | https://link.springer.com/article/10.1038/sj.onc.1210841 https://www.ncbi.nlm.nih.gov/pubmed/17922031 https://www.proquest.com/docview/227351029 https://www.proquest.com/docview/2641371500 https://www.proquest.com/docview/21302318 https://www.proquest.com/docview/70444109 https://pubmed.ncbi.nlm.nih.gov/PMC2676674 |
| Volume | 27 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1476-5594 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0007902 issn: 0950-9232 databaseCode: KQ8 dateStart: 19970101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1476-5594 dateEnd: 20151126 omitProxy: true ssIdentifier: ssj0007902 issn: 0950-9232 databaseCode: ABDBF dateStart: 19970109 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1476-5594 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0007902 issn: 0950-9232 databaseCode: AFBBN dateStart: 19970109 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1476-5594 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0007902 issn: 0950-9232 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1476-5594 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0007902 issn: 0950-9232 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1476-5594 dateEnd: 20191231 omitProxy: true ssIdentifier: ssj0007902 issn: 0950-9232 databaseCode: 8C1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3rb9MwED_BJh4SQlBeYaP4AxJ88ZY4DyefUFe1TEib0GBSv0WJ7WidRlKaDon_nrvEyQh0qFJV1afYsc_n3z18B_BOhSaSwiXXoMl4UAj85QvFUW_LtC8kigeyQ56cRsfnwedFuLAGt9qGVXYysRHUulJkIz_Eg9vzJcIX9-PqB6eqUeRdtSU07sKuh1CFuFoueoXLlW3MIaIIlyOQEV3SRj8-rC8PKtyAlD4rDrzBoWRF86NVVuM0FW19i20A9N84yr-cqc0ZNX8Cjy24ZJOWG57CHVOO4F5bbvLXCB5Mu-puI7h_Yp3qz-Arsgo7u6g-zeZMV9-zZcmqgq1wzOxIrfkkv2J0--EnoVKim7Cs1GxZs7WhMGKjGQJftvkDAVflczifz75Nj7mttcBVJOWGJzo3oaR7WInWstASkU2GKitqR16QU546T8tcJoXKvTjJUakOY3ICRqRPEWZ4ATtlVZpXwCKZCW0Cg1APsYNfJHksgyTHvwsloix0gHeTnSqbiJzqYVyljUPcj9P6MsXFSe3iOPC-p1-1KThup6S1S2lv4hNVZq8Y4Lgoy1U68cgUkODYHdgfUOLkq0HzeLD6fb9kKsJP4MBexw6p3fR1KhAKoogTCT59S2vPwA687ZupYwpzK011jTTkRkYpezuFpPx-notdvGx572ZKZCIEimgH5IArewJKJD5sKZcXTUJxEckokvhSHzr-vRn29pl-_f833IOHbVyNz4Xch53N-tq8QfC2ycfNDsXveOqNYfdodvrl7DffvUFi |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKoEgIwfIKLa0PILiEJk42Tg4ILaXLlnZ7gFbam0lsR92qJMtmC-pP8Y3M5FUCW25VLlE8sh3PeB6e8QzAC9U3geAOuQZNbPspxzePKxvttlh7XCB7oHPI8WEwOvY_TfqTFfjV3IWhsMqGJ5aMWueKzsi3UXC7nkD1xXk3-25T1SjyrjYlNCqy2DcXP9FkK97ufUD8vuR8uHu0M7LrqgK2CoRY2JFOTF_QjaNIa5FqtONFjMYZ2gGun1BGNleLRESpStwwStB87Ifk7grIciDpiP3egJu-5_iUq19MWgPPEVWMI_bh2Kg48SZJpBduF6dvctzwlK4r9N2OEKxFwd1ZXCBa0qqexjKF99-4zb-ct6VMHN6He7UyywYV9T2AFZP14FZV3vKiB2s7TTW5Htwe1078h_AFSZN9Psk_7g6Zzr_F04zlKZvhnNl7NbcHyRmj2xY_SAsmuAGLM82mBZsbCls2mqGizRZ_aNx59giOrwULj2E1yzPzFFggYq6Nb1C1RF3FS6MkFH6U4OdU8SDuW2A3iy1Vnfic6m-cydIB74WyOJWIHFkjx4JXLfysSvlxNSThThIvwB5VXF9pwHlRVi05cOnoIcK5W7DRgcTFV53mzQ7223HpaAof34L1hhxkzWQKyVH1RJbKI-x9SWu7YSzYaptpYAqry0x-jjDktkaufjWEoHyCroNDPKlo73JJRMQ5igQLRIcqWwBKXN5tyaYnZQJzHoggEPhTrxv6vZz28pV-9v8_3IK10dH4QB7sHe6vw50qpsezudiA1cX83DxHxXGRbJa7lcHX62YPvwG9hniN |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dT9RAcIIYwcQYPUUrCPug0Zd67fZj2gdjTuAEEWJUknurbXcbjmB7Xg8Nf81f58z1A6uHb6QvTXeyu92ZnY-d2RmAZ6mnfZQWuwZ1bLqZpDdHpibZbbFyJBJ74HPIwyN_79h9P_JGS_CruQvDYZUNT5wzalWkfEbeJ8FtO0jqi9XP6rCIjzvDN5PvJleQYk9rU06jIpEDffGTzLfy9f4O4fq5lMPdL9t7Zl1hwEx9xJkZqkR7yLePQqUwU2TTY0yGGtkEtptwdjZbYYJhliZ2ECZkSnoBu758tiJYUlK_N-AmOq7D4WQ4ao09C6t4R-rDMkmJkk3CSCfol6evCtr8nLorcO2OQKzFwp1JXBKKsqq2xiLl998Yzr8cuXP5OLwHd2vFVgwqSrwPSzrvwa2q1OVFD1a3m8pyPVg5rB36D-Azkan4dFK82x0KVXyLx7koMjGhOYu36dQcJGeCb178YI2Y4QYizpUYl2KqOYRZK0FKt5j9oX0X-UM4vhYsrMFyXuT6MQgfY6m0q0nNJL3FycIkQDdM6HOWSj_2DDCbxY7SOgk61-I4i-bOeCeIytOIkBPVyDHgRQs_qdJ_XA3JuIuYL1CPaVxfb6B5cYataGDzMURIczdgowNJi592mjc72G_H5WMqelwD1htyiGqGU0aS1FBirzKk3he0tpvHgK22mQfmELtcF-cEwy5s4vBXQyDnFrQtGuJRRXuXS4KhlCQeDMAOVbYAnMS825KPT-bJzKWPvo_0Uy8b-r2c9uKVfvL_P9yCFWIM0Yf9o4N1uF2F9zimxA1Ynk3P9VPSIWfJ5nyzCvh63dzhN9yBfMg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+RhoGEF+domain+of+p210+Bcr-Abl+activates+RhoA+and+is+required+for+transformation&rft.jtitle=Oncogene&rft.au=Sahay%2C+S&rft.au=Pannucci%2C+N.L&rft.au=Mahon%2C+G.M&rft.au=Rodriguez%2C+P.L&rft.date=2008-03-27&rft.pub=Nature+Publishing+Group&rft.issn=0950-9232&rft.volume=27&rft.issue=14&rft.spage=2064&rft_id=info:doi/10.1038%2Fsj.onc.1210841&rft.externalDocID=A190749695 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-9232&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-9232&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-9232&client=summon |